Your browser doesn't support javascript.
loading
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan, John Gerry; Galiè, Nazzareno; Barberà, Joan Albert; Frost, Adaani E; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M; Kuwana, Masataka; McLaughlin, Vallerie V; Peacock, Andrew J; Simonneau, Gérald; Vachiéry, Jean-Luc; Blair, Christiana; Gillies, Hunter; Miller, Karen L; Harris, Julia H N; Langley, Jonathan; Rubin, Lewis J.
Afiliação
  • Coghlan JG; Cardiology Department, Royal Free Hospital, London, UK.
  • Galiè N; Department of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, Bologna, Italy.
  • Barberà JA; Department of Respiratory Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Frost AE; Biomedical Research Networking Center on Respiratory Diseases, Madrid, Spain.
  • Ghofrani HA; Houston Methodist Lung Center, Houston, Texas, USA.
  • Hoeper MM; Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.
  • Kuwana M; Hannover Medical School and German Center of Lung Research (DZL) Hannover, Hannover, Germany.
  • McLaughlin VV; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Peacock AJ; Univeristy of Michigan Health System, Ann Arbor, Michigan, USA.
  • Simonneau G; Regional Heart and Lung Centre, Glasgow, UK.
  • Vachiéry JL; Faculté de Médecine, Université Paris-Sud, Le Kremlin Bicêtre, France.
  • Blair C; Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
  • Gillies H; Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), UMR_S 999, INSERM, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France.
  • Miller KL; Universitaires de Bruxelles-Hôpital Erasme, Brussels, Belgium.
  • Harris JHN; Gilead Sciences, Inc., Foster City, California, USA.
  • Langley J; Former employee of Gilead Sciences, Inc., Foster City, California, USA.
  • Rubin LJ; Gilead Sciences, Inc., Foster City, California, USA.
Ann Rheum Dis ; 76(7): 1219-1227, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28039187
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilpropionatos / Piridazinas / Escleroderma Sistêmico / Inibidores da Fosfodiesterase 5 / Tadalafila / Hipertensão Pulmonar / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilpropionatos / Piridazinas / Escleroderma Sistêmico / Inibidores da Fosfodiesterase 5 / Tadalafila / Hipertensão Pulmonar / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido